Abstract
Introduction
Tuberculosis is one of the major worldwide public health concerns, with approximately 9 million of new TB cases notified annually. Regionally, the southern Africa includes some world's high TB burden countries and has experienced the rise of TB cases for the recent years, mainly driven by highest HIV prevalence and poor socio-economic conditions. Thus, accounting for a large share of the global tuberculosis (TB) burden. In addition TB has become a cross-border issue in the southern Africa (4, 14) .
Though it is curable and preventable, every day TB kills nearly 5,000 people (WHO, 1999 (WHO, , 2001 (WHO, , 2008 , and represents the second leading cause of death from infectious diseases after HIV. Without treatment, the morbidity and mortality rates from TB are high, mostly in low resources setting countries.
Taking into account the high proportion of TB patients in HIV prevalence population of sub Saharan particularly the southern Africa, where studies have shown that for each increase of 1% of HIV prevalence, there is an increase in TB notification rates of 13 cases/100,000, and considering Botswana as one of the highest TB notification rates per capita in the world(6) and also our professional experience on TB case management; there was a pressing need to assess the TB program performance from 2013 to 2015 at the Mabutsane sub district level in order improve the district TB program performance.
To this end, the following questions have to be addressed:  What is the TB cure rate?  What is the percentage of people who completed TB treatment?  What is the default rate?  What is the TB success rate? ISSN: 2520-3134
 How many TB patients tested for HIV?
Materials and methods
This descriptive study was done retrospectively for the period of July to September 2016. It includes the data of interest from 2013 to 2015, and explored Mabutsane sub district TB program achievements. it was carried out on various key program indicators which include but not limited to the treatment outcomes of registered patents, treatment group ( new and subcategories of previously treated patients or retreatment TB), HIV status. TB patients transferred out of the district are also part of this study. Patients with multidrug resistance were excluded, as well as those who had unknown treatment outcomes.
 Reports from national TB program are also not part of the study.  Data was collected electronically and manually from Mabutsane sub district TB register.  Data was reviewed and presented as tables, graphs and charts. Mabutsane is a rural sub district situated in the Southern district of Botswana along the Ghanzi road, approximately 300 km from Gaborone (Capital City of Botswana). Its health facilities include 5 clinics, 4 health posts, 2 mobile stop, one laboratory with sputum smear microscopy, Gene xpert, and integration of TB and community based care services. Directly Observed Therapy option for smear-positive Pulmonary TB patients for health facility supervision. Each facility provides TB treatment. There is no hospital in the district.
Results
Descriptive analyses were performed using percentages (proportions). This pie chart shows the proportion of 80% of TB patients who completed treatment. Of these, 30% were cured and 49% have completed treatment but not evaluated for sputum smear status at the end of treatment, and 1% represents the treatment failure.
At least 17 %( 12/70) of patients did not complete treatment. Of these, 1% of patients' defaulted treatment, 7% died, and 9% transferred out. However 3% were not evaluated for treatment outcomes.
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The treatment success rate, which is the sum of the patients who were cured and those who completed treatment but not evaluated for sputum status throughout the course of treatment, is 78.6 %( 30+48.6). This is well explained in the following diagram: This pie chart shows that 19% of patients were cured, 59% have completed but were not evaluated for sputum status at the end of treatment, and 2% of treatment failure.
DOI:
There were 9 % of patients, the proportion of patients who did not complete treatment mostly those who died. The default rate was 0.0%, and11% of patients were not evaluated for treatment outcomes.
There was no patient transferred out in this year under evaluation. The success rate for 2014, which is the sum of the cure rate of 19 %( 12/63) and the treatment completion of 59 %( 37/63) with no sputum evaluation at the end of treatment is 78 %( 19+59). This has been indicated summarized in the below diagram: Treatment completed with no sputum evaluation in 2015 was 56%; cure rate 11%, and treatment failure 2%.
Treatment not completed includes default (4%), death (11%), and transferred out (5%). 11% of patients were not evaluated The success rate is the sum of treatment completion that results in 67.1% (56 %+11.1%). It is summarized in the following diagram The figure1 reveals that between 75% and 80% of TB patients have completed treatment for the period of 2013 and 2014. However, in 2015, this proportion declines below 70%, and therefore explaining the low success rate for this period.
The proportion of patients who did not complete treatment is less than 10% in 2014, whereas in 2013 and 2015, it is between 10% and 20%. It appears that the cure rate ranges between 10 and 30%, whereas the treatment failure remains below 3% for the whole period under evaluation. This figure presents the comparative success rate situation for the period of 2013 to 2015. The success rate is markedly high over the first the two years of the study, but there is a decline in 2015 probably because of no documented treatment outcomes, and low cure rate. The default rate remains below 5% during the evaluation period. This figure indicates that the cure rate does not follow the sputum collection. This situation might be due to poor sputum collection during treatment, extra pulmonary TB or poor documentation. ISSN: 2520-3134 This figure shows that the proportion of patients who defaulted for the whole study period is below 5%. This table indicates that more 90% of TB patients know their HIV status over the whole study period. It appears that the TB/HIV co infection rate is between 40% and 60%. This is well detailed in the followed figure. This table reveals that the HIV testing rate is more than 90% over the whole study period, and the TB/HIV co infection rate is between 40-60%.
The TB/HIV co infection among those who know their HIV status was between 40-60%, proportion below the national target fixed at 60% to 80%.
Discussions
What is the TB cure rate?
These results are consistent with the previous studies. In fact, this unfavorable outcome in our study concerning the cure might be due to missing sputum reexaminations during treatment or poor evaluation or documentation. It indicates a weak program.
What is the proportion of patients who completed TB treatment?
The completeness of treatment has been shown higher or very low in other parts of the Botswana. it has been reported low in most high TB burden countries.
The difference between this study and other studies could be explained by differences in sample size.
What is the default rate?
This indicated that the default rate for this period of 2013-2015 was less than 5%. This is consistent with other published reports, such as the world's 22 high-burden countries, where this proportion ranges from less than 1% to 13%.
What is the TB success rate in Mabutsane sub district?
The proportion of success rate is remarkably higher in previous studies or some parts of Botswana. Globally, the success rate was estimated at 83% in 2014, and it was 90% or more in eight of 30 TB burden countries, western pacific region and the Eastern Mediterranean region in 2014.
In the Southern Africa it was highest in Zambia (85%), followed by Zimbabwe (81%), south Africa (78%), Lesotho (70%), Angola (34%) (1) .
In other parts of Africa for example, Tanzania has recorded a success rate of 81% against 70% in Uganda (WHO, 2010), whereas in Ethiopia the successful outcome was 83% for the period of 2011-2015(Gebretsadik Berhe et al., 2012) 
